Raphaël Colle
Institute Mutualiste Montsouris(FR)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer, Cancer Immunotherapy and Biomarkers, Colorectal and Anal Carcinomas, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)(2020)164 cited
- → Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers(2022)110 cited
- → Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond(2019)107 cited
- → Immunotherapy and patients treated for cancer with microsatellite instability(2016)87 cited
- → Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer(2020)76 cited
- → Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer(2020)61 cited
- → Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency(2021)45 cited
- → Molecular Targets for the Treatment of Metastatic Colorectal Cancer(2020)45 cited
- → Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability(2023)45 cited
- → BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors(2023)34 cited